help_outline Skip to main content

News / Articles

FDA approves first generic naloxone nasal spray to treat opioid overdose

Published on 4/23/2019

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636333.htm

 
Return to Previous Page

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here

Insert a link here